rna
interfer
rnai
conserv
sequencespecif
genesilenc
mechan
induc
doublestrand
rna
rnai
hold
great
promis
novel
nucleic
acidbas
therapeut
wide
varieti
diseas
includ
cancer
infecti
diseas
genet
disord
antivir
rnai
strategi
receiv
much
attent
sever
compound
current
test
clinic
trial
although
induc
rnai
abl
trigger
profound
specif
inhibit
viru
replic
becom
clear
rnai
therapeut
straightforward
initi
hope
difficulti
concern
toxic
deliveri
right
cell
earlier
hamper
develop
antisensebas
therapeut
may
also
appli
rnai
addit
indic
virus
evolv
way
escap
rnai
proper
consider
issu
necessari
design
rnaibas
therapeut
success
clinic
intervent
human
pathogen
virus
recent
year
known
emerg
virus
pose
increasingli
seriou
threat
public
health
effect
vaccin
antivir
drug
avail
virus
rnai
therefor
welcom
scientif
commun
potenti
power
new
tool
target
virus
result
vitro
studi
anim
model
indic
rnai
therapeut
highli
effect
low
dosag
make
outstand
candid
futur
clinic
use
inde
sever
rnaibas
antivir
drug
current
test
clinic
trial
tabl
develop
rnai
therapeut
take
place
unpreced
speed
move
obscur
phenomenon
report
plant
caenorhabd
elegan
therapeut
compound
clinic
trial
year
sinc
first
report
rnaimedi
inhibit
human
pathogen
respiratori
syncyti
viru
rsv
ref
mani
virus
success
target
rnai
see
review
jh
bb
includ
among
other
import
human
pathogen
human
immunodefici
viru
type
hepat
c
viru
hcv
hepat
b
viru
hbv
sever
acut
respiratori
syndrom
coronaviru
sarscov
influenza
viru
rnai
technolog
latest
long
line
nucleic
acidbas
drug
candid
includ
antisens
dna
rna
decoy
ribozym
aptam
fig
tabl
develop
therapeut
modal
sever
hamper
practic
problem
toxic
instabl
serum
deliveri
year
problem
solv
use
chemic
modifi
nucleic
acid
instead
unmodifi
dnarna
oligonucleotid
modif
phosphorothio
dna
rna
peptid
nucleic
acid
pna
lock
nucleic
acid
lna
morpholino
phosphoroamid
increas
affin
oligonucleotid
target
sequenc
increas
serum
stabil
despit
intens
effort
test
differ
chemic
modif
extrem
difficult
design
potent
antivir
toxic
cell
overview
antivir
nucleic
acid
therapi
clinic
trial
provid
tabl
although
signific
differ
mechan
effici
antisens
rnaibas
therapeut
approach
clear
latter
share
mani
problem
former
need
resolv
achiev
clinic
success
import
concern
includ
viral
escap
rnai
offtarget
effect
rnai
treatment
deliveri
rnaiinduc
right
target
cell
review
discuss
rnai
strategi
inhibit
viru
infect
describ
viral
countermeasur
virus
escap
rnai
inhibit
consid
activ
countermeasur
induc
viral
resist
replic
cycl
viru
may
also
provid
intrins
protect
rnai
attack
classifi
passiv
countermeasur
nucleic
acidbas
antivir
strategi
equal
sensit
passiv
activ
viral
strategi
highlight
promis
therapeut
option
design
potent
rnaibas
antivir
import
understand
underli
mechan
function
rnai
cell
biolog
rnai
play
pivot
role
regul
gene
express
posttranscript
level
microrna
mirna
mirna
small
noncod
rna
express
primari
mirna
process
first
protein
drosha
dicer
nucleotid
nt
stemloop
precursor
mirna
premirna
matur
mirna
nt
respect
one
strand
matur
mirna
antisens
guid
strand
load
rnainduc
silenc
complex
risc
guid
strand
target
risc
mrna
partial
complementari
sequenc
trigger
mrna
cleavag
translat
inhibit
recent
suggest
stress
condit
mode
mirna
regul
chang
associ
protein
turn
activ
gene
express
current
estim
express
least
human
gene
regul
mirna
exact
criteria
target
recognit
current
clear
howev
pair
nucleotid
mirna
seed
region
multipl
site
untransl
region
target
mrna
mani
case
suffici
trigger
translat
inhibit
rnai
involv
inhibit
virus
silenc
transpos
element
plant
insect
fungi
nematod
smallinterf
rna
sirna
dsrna
process
dsrna
viral
replic
intermedi
sirna
load
risc
target
fulli
complementari
viral
rna
destruct
translat
repress
although
still
debat
accumul
evid
suggest
rnai
also
play
role
antivir
defens
mechan
mammalian
cell
exampl
retroviru
primat
foami
viru
type
vesicular
stomat
viru
vsv
inhibit
cellular
mirna
respect
express
reduc
dicerdefici
mice
caus
strong
increas
vsv
replic
addit
recent
paper
indic
cellular
mirna
suppress
express
mrna
rest
cell
suggest
mirna
play
role
establish
viral
latenc
express
mirna
decreas
activ
cell
allow
viru
replic
result
agreement
observ
cellular
mirna
express
pattern
significantli
influenc
viru
infect
addit
human
retrotransposon
long
interspers
nuclear
element
inhibit
transposonspecif
sirna
similar
describ
transposon
silenc
c
elegan
furthermor
data
suggest
accumul
virusspecif
sirna
replic
discuss
activ
passiv
viral
strategi
counter
antivir
rnai
respons
summar
fig
besid
possibl
antivir
rnai
effect
clear
intric
interplay
mammalian
virus
host
cell
rnai
machineri
particular
note
find
cellular
stimul
hcv
replic
yetunknown
mechan
addit
variou
herp
virus
encod
mirna
thought
target
specif
cellular
gene
herp
simplex
viru
type
express
antiapoptot
viral
mirlat
inhibit
induct
apoptosi
downregul
express
transform
growth
factor
tgf
ref
simian
viru
encod
mirna
regul
viral
gene
express
thu
reduc
recognit
infect
cell
immun
system
counter
antivir
rnai
respons
plant
invertebr
virus
evolv
protein
activ
interfer
distinct
step
rnai
machineri
ensur
high
viru
product
effici
viral
spread
suppressor
activ
also
report
mammalian
virus
fig
primat
retroviru
overcom
mirnamedi
antivir
pressur
rnai
suppressor
activ
ta
protein
mammalian
virus
also
encod
viral
factor
exhibit
rnai
suppress
activ
either
protein
influenza
viru
vaccinia
viru
hcv
core
ta
tat
ebola
viru
protein
rna
adenoviru
virusassoci
rna
ii
vai
vaii
recent
show
function
replac
tat
protein
support
viru
product
tatminu
viru
variant
suggest
rnai
figur
nucleic
acidbas
antivir
strategi
antivir
nucleic
acid
either
transfect
cell
eg
sirna
antisens
oligonucleotid
express
intracellularli
shrna
ribozym
rna
decoy
viral
transcript
complementari
sirnashrna
cleav
upon
assembl
risc
machineri
risc
abl
target
rna
genom
protect
within
viral
capsid
shield
rnai
attack
subcellular
compart
eg
nucleu
virusinduc
vesicl
modifi
antisens
oligonucleotid
high
affin
target
sequenc
inhibit
gene
express
steric
hindranc
ribosom
splice
within
nucleu
induct
mrna
cleavag
recruit
rnase
h
bind
ribozym
target
sequenc
also
trigger
cleavag
viral
rna
decoy
rna
bind
sequest
essenti
viral
protein
host
cell
factor
support
viru
replic
elbashir
cowork
first
show
transfect
synthet
sirna
could
induc
rnaimedi
gene
silenc
mammalian
cell
synthet
sirna
duplex
gener
long
overhang
model
natur
dicer
cleavag
product
upon
dsrna
transfect
antisens
strand
sirna
load
risc
subsequ
target
viral
rna
sequencespecif
manner
similar
antisens
oligonucleotid
synthet
sirna
rel
unstabl
vivo
due
degrad
nucleas
chemic
modif
previous
use
increas
vivo
halflif
antisens
compound
use
stabil
sirna
howev
modif
neg
effect
sirna
activ
addit
enhanc
stabil
activ
vitro
may
translat
activ
compound
vivo
transfect
plasmid
express
antivir
shorthairpin
rna
shrna
also
commonli
use
induc
rnai
mammalian
cell
base
pair
bp
shrna
model
premirna
small
apic
loop
uu
overhang
shorthairpin
rna
express
nucleu
polymeras
iii
promot
transloc
cytoplasm
process
dicer
cytoplasm
function
sirna
recent
activ
shrna
significantli
improv
inclus
rna
structur
motif
mimic
natur
mirna
improv
shrna
shrnamir
express
larger
transcript
contain
bulg
nucleotid
larg
loop
mimick
structur
primari
premirna
anoth
way
induc
rnai
intracellular
express
longhairpin
rna
lhrna
contrast
transfect
dsrna
larger
bp
intracellular
express
seem
induc
interferon
respons
effici
inhibit
lhrna
report
hcv
hbv
potenti
advantag
lhrna
inhibitor
gener
multipl
sirna
singl
precursor
molecul
may
prevent
viral
escap
potent
durabl
inhibit
viru
replic
import
target
viral
rna
genom
transcript
encod
essenti
viral
factor
addit
import
target
sequenc
conserv
among
differ
viru
strain
reduc
chanc
escap
nevertheless
virus
tend
escap
rnai
inhibit
mutat
target
sequenc
host
factor
essenti
viral
replic
also
target
approach
may
reduc
chanc
viral
escap
howev
host
factor
target
without
affect
host
cell
viabil
wellknown
exampl
one
host
factor
cc
motif
receptor
coreceptor
import
viru
entri
yet
mutat
gene
known
compat
normal
life
learn
virus
interact
cellular
rnai
pathway
new
target
antivir
therapeut
may
becom
evid
discuss
hcv
requir
replic
possibl
cofactor
could
target
antagomir
antisens
oligonucleotid
specif
inhibit
mirna
function
mirna
function
believ
highli
redund
silenc
singl
mirna
could
well
toler
cell
inhibit
express
result
increas
histon
acetylas
pcaf
camp
respons
element
bind
protein
cbp
associ
factor
express
requir
optim
transcript
overexpress
shown
reduc
pcaf
express
result
reduc
viru
replic
overexpress
natur
mirna
may
possibl
result
less
unwant
side
effect
case
manmad
sirna
cellular
mirna
inde
target
viral
mrna
silenc
viral
rnai
suppressor
could
derepress
mirna
result
multipl
mirna
attack
although
consensu
sever
report
suggest
similar
situat
plant
exogen
sirna
trigger
promot
methyl
sequencespecif
manner
mammalian
cell
use
sirna
trigger
transcript
silenc
may
repres
altern
rnai
inhibit
strategi
target
dna
retrovirus
transient
transfect
synthet
sirna
plasmid
encod
shrna
probabl
best
suit
treatment
acut
viru
infect
respiratori
virus
ideal
target
therapi
approach
upper
airway
lung
rel
easi
target
rnai
therapeut
compound
could
administ
via
aerosol
deliveri
devic
similar
one
use
deliveri
asthma
therapeut
even
partial
reduct
peak
viral
load
significantli
reduc
avoid
diseas
symptom
viru
clear
thereaft
immun
system
mice
treat
sirna
influenza
viru
rsv
sarscov
show
reduc
viru
titer
reduc
virusinduc
mortal
prophylact
treatment
establish
infect
interestingli
report
sirna
treatment
effect
without
transfect
reagent
intranas
administr
plasmid
express
shrna
rsv
also
result
signific
decreas
viral
titer
potent
sirna
inhibitor
sarscov
spike
polymeras
gene
shown
reduc
sarslik
symptom
viral
rna
level
lung
histopatholog
rhesu
macaqu
recent
alnylam
pharmaceut
cambridg
usa
announc
initi
phase
clinic
trial
sirna
treatment
rsv
tabl
phase
trial
advers
effect
observ
safeti
toler
antivir
activ
sirna
test
adult
experiment
infect
rsv
contrast
acut
viru
infect
chronic
infect
virus
hcv
hsv
target
longterm
rnai
treatment
scenario
gene
therapi
approach
need
provid
constant
suppli
intracellularli
express
antivir
shrna
case
one
could
make
virusresist
cell
ex
vivo
transduct
blood
stem
cell
express
rnai
trigger
give
cell
back
patient
differ
viral
vector
use
stabli
transduc
cell
shrna
express
construct
shown
viru
replic
strongli
inhibit
cell
transduc
lentivir
shrna
vector
unfortun
prolong
cultur
cell
result
select
escap
variant
becom
resist
express
sirna
induc
rnai
block
replic
like
absolut
allow
escap
variant
evolv
resist
variant
contain
singl
nucleotid
substitut
delet
within
sirnatarget
sequenc
fig
acquisit
delet
report
nonessenti
nef
gene
target
escap
rout
occur
essenti
viral
gene
target
k
van
eij
ter
brake
bb
unpublish
data
bb
colleagu
suggest
theoret
virus
also
escap
drugpressur
select
sequenc
insert
yet
report
inhibit
rnai
similar
escap
targetsit
mutat
report
virus
polioviru
suggest
singl
nucleotid
substitut
target
sequenc
suffici
overcom
antivir
activ
sirna
although
mutat
may
requir
full
resist
result
confirm
exquisit
sequencespecif
rnai
besid
escap
variant
mutat
target
group
identifi
variant
obtain
resist
select
upstream
mutat
mutat
induc
altern
local
rna
structur
target
sequenc
particular
end
occlud
sirnarisc
bind
result
highlight
impact
target
rna
structur
rnai
indic
altern
way
virus
evad
rnaimedi
inhibit
design
potent
antivir
rnai
therapeut
one
must
investig
local
rna
secondari
structur
target
sequenc
protect
role
rna
structur
discuss
detail
describ
intrins
viral
replic
properti
avoid
rnai
attack
fig
thu
singl
sirna
therapi
suffici
obtain
longterm
inhibit
viru
replic
escap
rnai
reminisc
evolut
drugresist
variant
individu
antiretrovir
therapi
combin
use
multipl
antivir
drug
perman
block
viru
replic
prevent
emerg
resist
variant
similarli
combin
express
multipl
sirna
would
requir
persist
block
viru
replic
combinatori
approach
target
viral
sequenc
essenti
well
conserv
among
differ
viru
strain
even
overexpress
multipl
shrna
increas
chanc
offtarget
effect
toxic
satur
cellular
rnai
pathway
satur
concentr
sirnashrna
may
interfer
cellular
mirna
process
function
shown
potenti
fatal
consequ
mice
treat
viral
vector
overexpress
shrna
liver
virus
escap
induc
rnaimedi
inhibit
evolv
altern
rna
structur
shield
target
sequenc
find
suggest
virus
may
use
highli
structur
rna
mean
evad
natur
antivir
rnai
respons
inde
describ
plant
viroid
pathogen
small
nt
noncod
singlestrand
circular
rna
genom
adopt
quasi
rodshap
structur
intramolecular
base
pair
viroid
encod
protein
evolv
protein
suppressor
counteract
rnai
induc
dsrna
natur
viroid
genom
fig
therefor
viroid
may
evolv
structurebas
replic
strategi
becom
inaccess
risc
resist
rnai
circular
genom
antigenom
rna
hepat
delta
viru
hdv
requir
hbv
helper
viru
replic
rnai
resist
resist
ascrib
inaccess
base
nuclear
local
even
genom
rna
enter
cytoplasm
inaccess
rnai
attack
viroidlik
structur
base
pair
altern
bind
host
rnabind
protein
anoth
exampl
rnai
resist
base
rna
structur
describ
region
rhinoviru
rna
genom
rnai
target
region
ineffect
probabl
stabl
rna
structur
genom
end
similar
result
obtain
gitlin
et
al
target
well
conserv
highli
structur
noncod
region
polioviru
rna
genom
note
rnaprotein
interact
may
also
neg
influenc
rnai
sensit
optim
inhibit
viru
replic
import
target
viru
earli
stage
viru
replic
inevit
rnai
target
viral
rna
viru
enter
cell
case
rna
virus
incom
rna
genom
would
import
target
fig
howev
turn
viral
genom
rna
difficult
target
rnai
rna
genom
retrovir
particl
seem
ideal
target
rnai
revers
transcrib
dna
nucleocapsid
particl
rou
sarcoma
viru
shield
incom
viral
rna
rnaimedi
degrad
contradictori
report
whether
incom
rna
genom
target
rnai
address
issu
use
hivbas
lentivir
transduct
quantit
model
infect
found
target
argu
cytoplasm
core
particl
like
inaccess
risc
complet
coverag
viral
rna
genom
nucleocapsid
protein
may
also
help
resist
rnai
attack
abil
evad
rnaimedi
target
incom
genom
frustrat
therapeut
action
prevent
establish
integr
dna
proviru
word
therapeut
effect
due
target
newli
synthes
viral
transcript
inhibit
viru
product
therefor
difficult
tailor
rnai
strategi
prophylact
vaccin
prevent
infect
initi
experi
rnaimedi
inhibit
rsv
observ
negativestrand
genom
rna
target
rsv
protect
cytoplasm
genom
nucleoprotein
oligomer
along
viral
rna
form
ring
structur
rna
sequest
therebi
protect
risc
antivir
sirna
similar
structur
recent
report
rabi
viru
vsv
even
viral
rna
genom
cover
viral
chaperonin
protein
known
facilit
rnarna
interact
indic
class
rnabind
protein
stimul
anneal
sirnarisc
complex
rna
replic
intermedi
locat
cytoplasm
theoret
target
risc
wherea
nuclear
rna
molecul
may
protect
rnai
machineri
fig
exampl
influenza
viru
genom
rna
local
nucleu
therefor
resist
rnai
wherea
cytoplasm
mrna
molecul
effici
target
reovirus
dsrna
virus
replic
viral
inclus
form
cytoplasm
infect
cell
dsrna
genom
resid
inclus
protect
rnai
flavivirus
reorgan
endoplasm
reticulum
membran
rna
genom
protect
rnai
attack
silenc
picornaviru
effici
target
positivestrand
rna
negativestrand
rna
might
indic
negativestrand
rna
protect
within
membraneassoci
replic
complex
wherea
positivestrand
rna
leav
complex
function
mrna
make
suscept
riscmachineri
contrast
rnai
strategi
littl
known
viral
escap
option
nucleic
acidbas
therapeut
inhibit
gene
express
antisens
approach
reli
recruit
cellular
silenc
mechan
instead
inhibitori
effect
larg
base
strong
bind
antisens
oligonucleotid
target
mrna
block
splice
event
elong
ribosom
steric
hindranc
addit
unmodifi
dna
phosphorothioatemodifi
oligonucleotid
may
induc
rna
cleavag
activ
cellular
rnase
h
enzym
specif
recogn
dnarna
duplex
escap
antisens
inhibit
report
sarscov
inhibit
morpholinomodifi
oligonucleotid
antisens
oligonucleotid
target
transcriptionregulatori
sequenc
import
process
discontinu
transcript
mutat
cuc
motif
aaa
enabl
viru
restor
viru
replic
howev
viru
replic
still
strongli
attenu
might
indic
escap
antisens
therapeut
easi
escap
rnai
data
avail
viru
escap
antivir
ribozym
howev
point
mutat
target
sequenc
prevent
effici
bind
ribozym
therefor
result
escap
decoy
aptam
bind
sequest
viral
factor
like
suffer
escap
although
detail
studi
lack
absenc
experiment
evid
may
taken
posit
sign
antivir
strategi
care
taken
weak
nonspecif
inhibitor
trigger
select
escap
virus
viral
rna
equal
sensit
rnai
attack
may
result
protect
protein
bind
viral
rna
protect
rna
structur
viral
rna
resid
viru
particl
subcellular
compart
survey
rnai
machineri
fig
seem
difficult
imposs
redirect
rnai
compart
interest
approach
target
retrovir
rna
genom
within
viru
particl
mean
specif
antisens
oligonucleotid
instruct
intravirion
rnase
h
enzym
cleav
viral
genom
special
countermeasur
also
design
neutral
viral
evas
mechan
exampl
use
multipl
effect
shrna
singl
lhrna
produc
multipl
antivir
sirna
combin
therapi
give
addit
inhibit
also
rais
genet
threshold
escap
multipl
target
acquir
mutat
viral
escap
appar
addit
benefit
escap
variant
may
reduc
viral
fit
particular
variant
acquir
mutat
sequenc
highli
conserv
among
viru
isol
prefer
viral
escap
rout
frequent
observ
singl
shrna
inhibitor
one
could
consid
multipl
shrna
approach
escap
mutat
anticip
select
counter
shrna
previous
outlin
inclus
cellular
cofactor
rnai
target
also
like
make
viral
escap
difficult
possibl
viral
sequenc
protect
stabl
rna
structur
may
target
modifi
sirna
duplexinvad
properti
bind
high
affin
target
viral
protein
may
frustrat
rnai
attack
act
rnai
suppressor
bind
rna
target
case
one
may
consid
target
viral
mrna
encod
protein
recent
studi
underscor
import
rnai
eukaryot
cell
biolog
antivir
rnai
strategi
coopt
exist
mechan
may
therefor
effici
nucleic
acidbas
antivir
multipl
clinic
rnai
applic
current
test
transient
therapi
rsv
durabl
gene
therapi
howev
take
account
virus
host
cell
coevolv
million
year
virus
develop
mechan
escap
rnai
thu
better
understand
natur
virusrnai
interact
key
develop
effect
rnaibas
antivir
drug
improv
activ
specif
deliveri
rnai
induc
critic
first
step
follow
detail
screen
unwant
side
effect
possibl
potent
antivir
construct
design
mirnalik
transcript
viral
target
equal
suitabl
effect
inhibit
rnai
import
identifi
viral
achil
heel
rnai
attack
given
immens
interest
rnai
therapeut
modal
come
year
like
see
increas
rang
clinic
applic
realiz
potenti
rnai
therapi
address
human
viral
pathogen
suggest
field
promis
futur
